Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.35 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.35 |
| ▸ | RARB | P10826 | 4/20 | 0.35 |
| ▸ | RARA | P10276 | 2/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30106832 | 1.00 | S1PR1 (0.35) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL12625465 | 1.00 | S1PR1 (0.35) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL12625441 | 0.99 | S1PR1 (0.35) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL1813180 | 0.97 | GRM2 (0.37) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL12625449 | 0.96 | S1PR1 (0.33) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL21564996 | 0.95 | RARB (0.37) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL12623683 | 0.94 | S1PR1 (0.35) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL18061215 | 0.94 | GRM2 (0.37) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL16683680 | 0.93 | S1PR1 (0.33) | S1PR1S1PR3RARBRARARARG | |
| SCHEMBL3439570 | 0.93 | RARB (0.41) | S1PR1S1PR3RARBRARARARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4317124-A1 | METHOD FOR PRODUCING ORGANIC FLUORINE COMPOUNDS | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-11053441-B2 | Liquid crystal composition and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2021-07-06 | — | — | US | disclosed |
| US-10788715-B2 | Photo-alignment material and photo-alignment method | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2020-09-29 | — | — | US | disclosed |
| US-10723947-B2 | Liquid crystal composition and liquid crystal display device thereof | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-07-28 | — | — | US | disclosed |
| US-20200123443-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-04-23 | — | — | US | disclosed |
| WO-2020026583-A1 | LIQUID CRYSTAL COMPOUND COMPRISING BENZOTHIAZOLE RING AND CF2O LIGAND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC株式会社 | 2020-02-06 | — | — | WO | disclosed |
| US-20190345387-A1 | LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL DISPLAY DEVICE EMPLOYING THE SAME | DAXIN MATERIALS CORPARATION (TW) | 2019-11-14 | — | — | US | disclosed |
| US-20190086738-A1 | PHOTO-ALIGNMENT MATERIAL AND PHOTO-ALIGNMENT METHOD | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2019-03-21 | — | — | US | disclosed |
| US-10017694-B2 | Liquid crystal medium containing 2,4-diflurophenyl compounds and use | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2018-07-10 | — | — | US | disclosed |
| US-20180171229-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DIC CORPORATION (JP) | 2018-06-21 | — | — | US | disclosed |
| US-20120229751-A1 | LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120099039-A1 | CHLOROBENZENE DERIVATIVE, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-04-26 | — | — | US | disclosed |
| US-20120068114-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20120029194-A1 | LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP | CHISSO PETROCHEMICAL CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20120015115-A1 | DISPLAY PANEL | AU OPTRONICS CORPORATION (TW) | 2012-01-19 | — | — | US | disclosed |
| US-7709066-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-05-04 | — | — | US | disclosed |
| US-20090091703-A1 | satisfies at least one characteristic such as high maximum temperature of nematic phase, a low minimum temperature of a nematic phase, a small viscosity, a large optical anisotropy, a large dielectric anisotropy, a large specific resistance, high stability to ultraviolet light and high stability to heat | CHISSO CORPORATION (JP) | 2009-04-09 | — | — | US | disclosed |
| US-7470456-B2 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2008-12-30 | — | — | US | disclosed |
| US-20070278450-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2007-12-06 | — | — | US | disclosed |
| US-20070278450-A1 | Liquid crystal composition and liquid crystal display device | CHISSO CORPORATION | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120099039-A1 | CHLOROBENZENE DERIVATIVE, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM, AND OPTICAL DEVICE | CRYAB, CYBA, CCNB1 | S1PR1 4265/4885S1PR3 3929/4885RARB 153/4885 |
| US-20120029194-A1 | LIQUID CRYSTAL COMPOUND HAVING DIFLUOROPROPENYLENEOXY BONDING GROUP | LEF1, EIF4A3, TCF4 | S1PR1 2027/4885S1PR3 1406/4885RARB 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.